EB vaccine adjuvant (University of Wisconsin-Madison)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameEB vaccine adjuvant (University of Wisconsin-Madison)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A